LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW
Liminatus Pharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.11+0.07 (+2.30%)
Close on Oct 19, 2026
- Market cap
- $150.52M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Liminatus Pharma's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Chris Kim | 9,617,954 | 14.30% | 13D (active) amendment | Jul 2, 2026 |
| Iris Acquisition Holdings LLC | 6,900,000 | 26.50% | 13D (active) | Apr 30, 2025 |
| Ewon Comfortech Co., Ltd. | 5,500,000 | 10.90% | 13G (passive) amendment | Jun 24, 2026 |
| KH Feelux Co., Ltd | 4,000,000 | 15.40% | 13G (passive) | Apr 30, 2025 |
| Samda Biolab Co., Ltd. | 3,426,548 | 5.10% | 13G (passive) | Jul 2, 2026 |
| Nongae Apple Association 1st | 1,470,000 | 5.70% | 13G (passive) | Apr 30, 2025 |
| Red Peony Association 1st | 1,470,000 | 5.70% | 13G (passive) | Apr 30, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Chris Kim | Chief Executive Officer, Director, 10% owner | 6,169,406 | Jul 14, 2026 |
| Beom Kyu Choi | Chief Technology Officer | – | Apr 30, 2025 |
| Scott Dam | Chief Financial Officer | – | Apr 30, 2025 |
| Sang-Jin Lee | Head of Research & Development | – | Apr 30, 2025 |
| Byong Chul Yoo | Chief Science Officer | – | Apr 30, 2025 |
| II Philip Wayne Lemons | Director | – | Jul 23, 2025 |
| Richard JaiHwan Baek | Director | – | Jul 21, 2025 |
| Eun Sook Lee | Director | – | May 1, 2025 |
| Nicholas Fernandez | Director | – | Apr 30, 2025 |
| Ji Yeon Baek | Director | – | Apr 30, 2025 |
| Therapeutics LLC Valetudo | 10% owner | 5,244,351 | Jul 14, 2026 |
| Ewon Comfortech Co., Ltd. | 10% owner | 5,500,000 | Jul 6, 2026 |
| Acquisition Holdings LLC Iris | 10% owner | 6,900,000 | Aug 15, 2025 |
| KH Feelux Co., Ltd | 10% owner | 4,000,000 | Jun 27, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Therapeutics LLC Valetudo 10% owner | Jul 2, 2026 | Other | +3,448,926 | – | – | 5,244,351 |
| Therapeutics LLC Valetudo 10% owner | Jun 24, 2026 | Other | −4,373,603 | – | – | 1,795,803 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.